MiraDx news

MiraDx, in collaboration with the UCLA Jonsson Comprehensive Cancer Center, is conducting a clinical trial to validate a novel prostate cancer biomarker panel designed to help assess patients who were at a greater risk of having long-term toxicity in response to their radiation treatment, to help guide treatment decisions.

Treatment can involve radiation therapy, surgery, and/or hormone therapy

Radiation has the advantage of being non-invasive; however, the most chall

LOS ANGELES--(BUSINESS WIRE)--MiraDx, a Los Angeles-based molecular genetics company that transitioned its CLIA-certified laboratory to provide COVID-19 PCR testing, is further expanding access to skilled nursing facilities (SNFs) in California. This will help these facilities provide fast and accurate COVID-19 testing for health care personnel and residents in accordance with recently released guidelines issued by the Cali

For COVID-19 testing, there are two predominant tests on the market: viral tests and serum antibody tests.

Let’s take a look at the main differences between these two types of tests, like what they look for, when each is the most effective, and the logistics of providing each type.

1. Viral Tests

Viral, or PCR, tests determine if an individual currently has COVID-19 by testing for the virus itself through a swab of the nose or th